Literature DB >> 8709830

[Liver cell carcinoma as a late complication of Alagille syndrome (arterio-hepatic dysplasia)].

W Wegmann1, J Evison, N Schaub, L Kist, M Vest.   

Abstract

The Alagille syndrome which is also known as arterio-hepatic dysplasia is an autosomal dominant inherited disorder. In several cases cytogenetic studies revealed an interstitial deletion of the short arm of chromosome 20. The hypoplasia or paucity of the interlobular bile ducts causes a chronic intrahepatic cholestasis. The association with facial dysmorphia, embryotoxon posterior, pulmonary stenosis and vertebral deformities are required for the diagnosis of the complete Alagille syndrome. The occurrence of hepatocellular carcinoma as a late complication of the Alagille syndrome was recognized only 11 years after the first publication by Alagille et al. So far 15 cases complicated by hepatocellular carcinoma have been reported. There is one family where all four siblings suffered from hepatocellular carcinoma. Our own case concerns a 31 year old man who died of hepatocellular carcinoma. The postmortem study of his medical history reaching back to childhood allowed the diagnosis of an unrecognized Alagille syndrome.

Entities:  

Mesh:

Year:  1996        PMID: 8709830

Source DB:  PubMed          Journal:  Leber Magen Darm        ISSN: 0300-8622


  3 in total

1.  Hepatocellular carcinoma and regenerating nodule in a 3-year-old child with Alagille syndrome.

Authors:  Sylvia C Wetli; Eva S Gralla; Susanne Schibli; Enno Stranzinger
Journal:  Pediatr Radiol       Date:  2010-08-17

2.  Management of large hepatocellular carcinoma in adult patients with Alagille syndrome: a case report and review of literature.

Authors:  Susan Tsai; Ahmet Gurakar; Robert Anders; Dora Lam-Himlin; John Boitnott; Timothy M Pawlik
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

3.  Alagille syndrome and risk for hepatocellular carcinoma: Need for increased surveillance in adults with mild liver phenotypes.

Authors:  Emma A Schindler; Melissa A Gilbert; David A Piccoli; Nancy B Spinner; Ian D Krantz; Kathleen M Loomes
Journal:  Am J Med Genet A       Date:  2020-12-24       Impact factor: 2.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.